Happy to present our work on drug repurposing in treatment-resistant depression (10.1038/s41386-021-01059-6) at #ECNP2021 😀 thanks Oliver Pain Saskia Hagenaars Dr Cathryn Lewis alessandro serretti

Exome sequencing study published today shows that 95% of a Spanish/Latin American sample could be informed of at least one actionable #pharmacogenetic phenotype nature.com/articles/s4152…

PsychX talk on Monday 4 December from 16.30 to 17.30 CET. Emilio Fernandez Egea from the UK will share his insights on “Clozapine, psychosis and OCD. Where to start?” ecnp.eu/ecnpcongress/e…

Join us for the upcoming ECNP-PsychX talk on 4 March 16.30 CET: prof. Barbara Franke from The Netherlands will share her insights on "Modernising the concept of ADHD" ecnp.eu/ecnpcongress/e…

Upcoming ECNP PsychX talk on Monday 6 May 16.30 - 17.30 CEST. Sandra Sanchez-Roige from the USA will share her insights on Bringing genetics into the clinic: are we there yet? ecnp.eu/ecnpcongress/e…

We're thrilled to invite you to the upcoming PsychX talk, on Monday 4 November 16.30-17.30 CET. Joseph Kambeitz will share his insights on: Beyond labels: Potential and challenges of AI for improved diagnostics and treatment in neuropsychiatry ecnp.eu/ecnpcongress/e…

Progress in treatment resistance of mental disorders symposium presentation at EPA congress: thanks to Lina Jonsson, Bernhard Baune and Evelien Van Assche for presenting and the great collaboration within PSYCH_STRATA that led to these results